Ignite Creation Date:
2025-12-24 @ 5:21 PM
Ignite Modification Date:
2026-01-26 @ 1:02 AM
Study NCT ID:
NCT04831450
Status:
WITHDRAWN
Last Update Posted:
2022-08-04
First Post:
2021-04-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC)
Sponsor:
University of Miami
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-07-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-15
Completion Date Type:
ACTUAL
First Submit Date:
2021-04-01
First Submit QC Date:
None
Study First Post Date:
2021-04-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-01
Last Update Post Date:
2022-08-04
Last Update Post Date Type:
ACTUAL